Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges. (2023)
Attributed to:
Unlocking cortisol activation in muscle as a treatable cause of muscle wasting in kidney failure
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics15010237
PubMed Identifier: 36678864
Publication URI: http://europepmc.org/abstract/MED/36678864
Type: Journal Article/Review
Volume: 15
Parent Publication: Pharmaceutics
Issue: 1
ISSN: 1999-4923